Logos Global Management LP

Holdings History for BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO)

Symbol: BBIO on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2023			-1.5%	$0	0	-400,000	-100%	$67.61	Q4 2023
31 Dec 2023	call		-27%	$0	0	-500,000	-100%	$67.61	Q4 2023
30 Sep 2023		1.5%	+0.38%	$10,548,000	400,000	+100,000	+33%	$26.37	Q3 2023
30 Sep 2023	call	27%	-8.2%	$13,185,000	500,000	-150,000	-23%	$26.37	Q3 2023
30 Jun 2023		0.71%	+0.71%	$5,160,000	300,000	+300,000	NEW	$17.20	Q2 2023
30 Jun 2023	call	100%	+100%	$11,180,000	650,000	+650,000	NEW	$17.20	Q2 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.